Clinical trials
Prostatic Neoplasms, Castration-Resistant trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 18 |
| Completed | 15 |
| Terminated | 8 |
| Active, not recruiting | 4 |
| Withdrawn | 2 |
| No longer available | 1 |
| Temporarily not available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 7 |
| MacroGenics | 4 |
| Novartis Pharmaceuticals | 4 |
| Michael Graham PhD, MD | 3 |
| Nuvation Bio Inc. | 3 |
| Bayer | 2 |
| Bristol-Myers Squibb | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Pfizer | 2 |
| Arcus Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms, Castration-Resistant | 49 |
| Prostatic Neoplasms | 19 |
| Neoplasms | 7 |
| Neoplasm Metastasis | 4 |
| Neoplasms by Site | 4 |
| Prostatic Diseases | 4 |
| Breast Neoplasms | 3 |
| Genital Diseases, Male | 3 |
| Genital Neoplasms, Male | 3 |
| Male Urogenital Diseases | 3 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.